Search for: "Matthew v. State"
Results 21 - 40
of 3,555
Sort by Relevance
|
Sort by Date
9 May 2024, 10:01 pm
In the landmark case of Yick Wo v. [read post]
8 May 2024, 4:26 am
In comparison, Daniels may be the only authentic part of the entire case in New York v. [read post]
3 May 2024, 12:15 am
Matthew Bender & Co. 2023). [read post]
2 May 2024, 9:05 pm
District Court for the District of Oregon to dismiss Juliana v. [read post]
1 May 2024, 3:09 pm
By: Matthew J. [read post]
1 May 2024, 11:04 am
Wanda Little Fenimore, The Rhetorical Road to Brown v. [read post]
1 May 2024, 3:00 am
In the past day, the encampment, which sits between John V. [read post]
26 Apr 2024, 3:51 am
DouglasElliman, by nonparties Matthew George and Michael Moran, was also the broker of thesellers, Stephan Van Dam and Gail Pellett. [read post]
25 Apr 2024, 9:01 pm
On April 5, 2024, a jury in California federal court found a former corporate executive liable for insider trading in SEC v. [read post]
24 Apr 2024, 11:27 am
First, paraquat is closely regulated for agricultural use in the United States. [read post]
24 Apr 2024, 5:00 am
It was the criminal theory itself that seemed crafted around the standard for obscenity famously described by Supreme Court Justice Potter Stewart in the case of Jacobellis v. [read post]
22 Apr 2024, 5:00 am
Inst. v. [read post]
20 Apr 2024, 3:57 am
In Meinecke v. [read post]
19 Apr 2024, 5:01 am
On June 24, 2022, the United States Supreme Court overturned Roe v. [read post]
17 Apr 2024, 8:59 am
In State v. [read post]
16 Apr 2024, 9:05 am
utm_source=share&utm_medium=member_desktop Matt Stoller explains U.S. v. [read post]
16 Apr 2024, 8:12 am
By: Matthew J. [read post]
16 Apr 2024, 2:43 am
SEDLIK v. [read post]
14 Apr 2024, 9:05 pm
Pfizer did, but Matthew Panuwat did not seek to profit on that transaction. [read post]
13 Apr 2024, 3:33 pm
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
